Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Needle-track metastasis in diffuse intrinsic pontine glioma: Need for a standardized surgical strategy?

Neuro-oncology advances·2026

Same author

GIT1 loss of function causes a recognizable syndromic neurodevelopmental disorder.

Brain : a journal of neurology·2026

Same author

Ubiquitin-dependent degradation of p27Kip1 and p21Waf1/Cip1 by AMBRA1 ensures G1 and S phase progression and limits replication stress.

Nucleic acids research·2026

Same author

Guidance for the Diagnosis and Treatment of Rare Embryonal and Sarcomatous Brain Tumors-a Report from the Central Nervous System-International Registry for Rare Embryonal and Sarcomatous Tumors German Society of Pediatric Oncology and Hematology Study Group.

Klinische Padiatrie·2026

Same author

Comparative Analysis of the Prognostic Value of Simpson Grade Versus MRI-Based Extent of Resection Paradigms Across Meningioma Histomolecular Subgroups.

Neurosurgery·2026

Same author

Expanding the clinical spectrum of RNU4ATAC-opathies: more frequent and diverse than assumed.

Genetics in medicine : official journal of the American College of Medical Genetics·2026

Same journal

Precision Proteomic Profiling of Systemic Lupus Erythematosus-Correlating Disease Activity and Complement Levels with Clinical Phenotypes.

Biomedicines·2026

Same journal

The Role of Salivary Microbiota in Pancreatic Cancer: From Screening to Tumor Progression and Treatment Response.

Biomedicines·2026

Same journal

Diagnostic Utility of Surface Electromyography for Identifying Muscles Affected by Myofascial Trigger Points: A Scoping Review.

Biomedicines·2026

Same journal

Performance Assessment of a Locally Semi-Automated NGS-Based Workflow for Homologous Recombination Deficiency Testing in High-Grade Serous Ovarian Carcinoma.

Biomedicines·2026

Same journal

Coupling and Uncoupling Pleiotropy Between Hypertension and Type 2 Diabetes Contribute to Exploring Potential Heterogeneity in Cardiovascular Risk in East Asian Population.

Biomedicines·2026

Same journal

Maternal Response to Therapeutic Plasma Exchange in Early Gestation: A Case Series of Thrombotic Microangiopathies and Neurological Disorders.

Biomedicines·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 31, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

MicroRNAs Expression Profile in MN1-Altered Astroblastoma.

Francesca Gianno^1,2, Evelina Miele³, Claudia Sabato^4,5

¹Department of Radiological, Oncological and Anatomo-Pathological Sciences, University Sapienza of Rome, 00161 Rome, Italy.

|January 25, 2025

Summary

This summary is machine-generated.

MicroRNA (miRNA) deregulation in MN1-altered astroblastoma impacts recurrence risk. This rare tumor

Keywords:

MN1 rearrangement astroblastoma biological processes epigenetic methylation miRNA expression microRNA

More Related Videos

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation

Published on: July 23, 2012

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

Related Experiment Videos

Last Updated: May 31, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation

Published on: July 23, 2012

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

Area of Science:

Neuro-oncology
Molecular biology
Epigenetics

Background:

Astroblastoma is a rare glial neoplasm predominantly affecting young females.
The key molecular driver is the rearrangement of the Meningioma 1 (MN1) gene.
MicroRNAs (miRNAs) are critical regulators of gene expression with significant biological roles.

Purpose of the Study:

Investigate miRNA expression profiles in MN1-altered astroblastomas.
Determine the regulatory mechanisms (epigenetic and genetic) of deregulated miRNAs.
Correlate miRNA expression with biological processes and clinical characteristics.

Main Methods:

Analysis of 14 astroblastoma samples using DNA methylation profiling.
Detection of miRNA expression in 8 MN1-altered astroblastomas and 2 normal brain controls via Nanostring and RT-qPCR.
Investigation of miRNA promoter methylation status and bioinformatics analysis of target genes and biological pathways.

Main Results:

Thirty-nine miRNAs were deregulated in astroblastoma compared to normal brain tissue.
Downregulated miRNAs were associated with an increased risk of tumor recurrence.
Epigenetic deregulation of miRNA promoters was observed in 14 out of 32 investigated miRNAs.

Conclusions:

MN1-altered astroblastomas exhibit a distinct miRNA expression signature linked to specific biological pathways.
These pathways may correlate with the tumor's clinical and pathological features.
Understanding miRNA dysregulation offers potential for novel prognostic markers and therapeutic strategies for this rare tumor.